Loading news...
Shares of Butterfly Network, Inc. (NYSE: BFLY - Get Free Report) have earned an average recommendation of "Hold" from the six ratings firms that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product.
Butterfly Network, Inc. (BFLY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
/PRNewswire/ -- USANewsGroup.com News Commentary - AI is making its way through the halls of our entire medical system, and the implementation is accelerating
Butterfly Network is a semiconductor-based handheld ultrasound platform that layers software and AI on top of its stack. This way, BFLY aims to replace multi-probe, cart-based systems with one reconfigurable device. BFLY's Compass AI targets enterprise POCUS governance, QA, and documentation to integrate bedside scans into hospital workflows.
BKV, BMI and BFLY have been added to the Zacks Rank #5 (Strong Sell) List on February 27, 2026.
Butterfly Network, Inc. (BFLY) Q4 2025 Earnings Call Transcript
Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.08 per share a year ago.
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “Our fourth quarter 2025 performance shows that our strategy is.
NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced that it will participate at the TD Cowen 46th Annual Health Care Conference in Boston on March 3, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer; and Megan Carlson, SVP, Accounting & Finance – Chief Acc.
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced that its Butterfly iQ+/iQ3 and Compass AI™ ultrasound solution have achieved GovRAMP and TX-RAMP Authorizations. The certifications authorize the Company to sell cloud services to all state and local government agencies, including in the state of Texas. GovRA.
Butterfly Network (NYSE: BFLY - Get Free Report) and Strata Skin Sciences (NASDAQ: SSKN - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation. Profitability This table compares Butterfly Network
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer.
Butterfly Network (NYSE: BFLY - Get Free Report) and Privia Health Group (NASDAQ: PRVA - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends. Valuation and Earnings This table compares Butterfly
/PRNewswire/ -- USANewsGroup.com News Commentary - The global medical imaging market hit a massive $45.5 billion in 2026[1], marking a total structural shift
/PRNewswire/ -- The medical imaging world is hitting a massive reset button as AI-driven clinical intelligence transforms how we map the human heart. With the
Butterfly Network, Inc. (BFLY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the warrants (“Warrants”) — ticker symbol BFLY WS — each warrant exercisable for one share of Class A common stock at an exercise price of $11.50 with an expiration date of February 12, 2026 of Butterfly Network, Inc. (the “Company”) from the NYSE. The Company issued the Warrants in connection with its business combina.
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”, “the company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced that it expects to report revenue growth for the fourth quarter ended December 31, 2025 of at least 17% year over year. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “We enter 2026 with strong momentum and.
Butterfly Network, Inc. (NYSE: BFLY - Get Free Report) EVP John Doherty sold 60,182 shares of the company's stock in a transaction that occurred on Wednesday, January 7th. The stock was sold at an average price of $3.98, for a total value of $239,524.36. Following the completion of the transaction, the executive vice president owned 1,234,688